Product evaluation and supply chain committees are the gatekeepers of new technologies gaining entrance into hospitals. These multidisciplinary teams weigh evidence-based information on product quality and clinical data, patient safety, revenue enhancements, reimbursement considerations and more. A new or novel implant design does not guarantee hospital and surgeon adoption. Surgeon speaker Alan Davis, M.D., shares advice based on his service on the Cleveland Clinic Innovations Committee, Cleveland Clinic New Products and Supply Chain Committees and BioStar Capital’s Executive Team.
Learning Objectives:
● Understand how hospital product evaluation teams operate
● Learn how hospitals assess new product decisions
● Gain insight into the evolution of these committees
